Zacks Investment Research
30 Oct 2026, 10:51 UTC · 46m ago
New Strong Sell Stocks for October 30th
Impact · against what's priced in
The earnings revisions for BSX, NBHC, and NMRK are largely non-catalysts as they align with existing downward trends. BSX's minor revision is already accounted for in a price that reflects significant growth deceleration and operational setbacks.
- BSX−0.05
Already priced in
- The price assumes
lowered full-year organic growth guidance of 6.5% to 8.0% and the reduced earnings guidance of $3.34 to $3.41 per share
The 2.4% downward revision in earnings estimates over the last 60 days is marginal and consistent with a price that already reflects reduced guidance and a decelerated growth pace.
What BSX's price assumes · Sep 10
